All of the drugs in this Technology Appraisal must have received a positive opinion from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) before the first Appraisal Committee meeting. This will not have happened before the current scheduled meeting in February, therefore we will reschedule this appraisal and the first Committee meeting will take place on 24 April 2019.